Tag: CDC

February 21, 2018

Dynavax’s Hepatitis B Vaccine Recommended by CDC Advisory Committee

Dynavax Technologies (NASDAQ:DVAX) announced that the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted...
February 13, 2018

Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval

Abiomed (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today the launch of a new indication...
November 20, 2017

Focus Graphite Launches Phase III Drilling at its 100%-owned Lac Tétépisca Flake Graphite Project, Québec

Focus Graphite Inc. (TSXV:FMS) (OTCQX:FCSMF) (FSE:FKC) (“Focus” or the “Company”) is pleased to announce the commencement of Phase III drilling...
November 7, 2017

GeoVax Publishes Zika Vaccine Study Results

GeoVax Labs announced the publication of a new scientific paper detailing the latest on the company's efforts against Zika.
October 25, 2017

Edible Cannabis Industry Ripe for Disruptive Technology

As the edibles market expands, new technologies that help cannabinoids safely bypass the liver, and limit waste are needed.
October 5, 2017

BioCorRx To Launch New Weight Management Program

BioCorRx (OTCQB:BICX) has announced it will begin a pilot program for weight-loss with Atlantis Medical Wellness & Weight Loss Center...
August 14, 2017

Digi International Introduces Patented Data Logger

Digi International (NASDAQ:DGII) has announced the immediate availability of its patented Digi Data Logger, a wireless temperature monitoring and tracking...
August 1, 2017

FDA Advisory Committee Sends Dynavax Stock Soaring

Dynavax Technologies saw its stock jump over 70 percent on Monday thanks to a favorable review from the US Food...
June 5, 2017

GeoVax Shows New Data from Zika Vaccine

GeoVax Labs presented its research on the effectiveness of their Zika vaccine protection with mice.
May 17, 2017

Alternate Health Completes Zika Initial Study

Alternate Health announced the completion of a study to investigate the potential of using cannabinoid for treating post-Zik virus symptoms.